Cargando…

Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics

BACKGROUND: The visual system could be included in the diagnostic criteria for multiple sclerosis (MS) to demonstrate dissemination in space (DIS) and dissemination in time (DIT). OBJECTIVE: To investigate the diagnostic value of retinal asymmetry in MS. METHODS: A prospective, longitudinal study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nij Bijvank, Jenny, Uitdehaag, B M J, Petzold, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785044/
https://www.ncbi.nlm.nih.gov/pubmed/34764152
http://dx.doi.org/10.1136/jnnp-2021-327468
_version_ 1784638877520101376
author Nij Bijvank, Jenny
Uitdehaag, B M J
Petzold, Axel
author_facet Nij Bijvank, Jenny
Uitdehaag, B M J
Petzold, Axel
author_sort Nij Bijvank, Jenny
collection PubMed
description BACKGROUND: The visual system could be included in the diagnostic criteria for multiple sclerosis (MS) to demonstrate dissemination in space (DIS) and dissemination in time (DIT). OBJECTIVE: To investigate the diagnostic value of retinal asymmetry in MS. METHODS: A prospective, longitudinal study in individuals with MS (n=151) and healthy controls (n=27). Optical coherence tomography (OCT) was performed at 0, 2 and 4 years. Macular ganglion cell and inner plexiform layer (mGCIPL) thickness was determined as well as measures for retinal asymmetry: the inter-eye percentage difference (IEPD) and inter-eye absolute difference (IEAD). Receiver operator characteristics curves were plotted and the area under the curve (AUC) was calculated for group comparisons of the mGCIPL, IEPD, IEAD and atrophy rates. RESULTS: The diagnostic accuracy of both the IEPD and IEAD for differentiating bilateral and unilateral MS optic neuritis was high and stable over time (AUCs 0.88–0.93). The IEPD slightly outperformed the IEAD. Atrophy rates showed low discriminatory abilities for differentiating MS from controls (AUC 0.49–0.58). CONCLUSION: The inter-eye differences of the mGCIPL have value for demonstration of DIS but in individuals with longstanding MS not for DIT. This may be considered as a test to detect DIS in future diagnostic criteria. Validation in a large prospective study in people presenting with symptoms suggestive of MS is required.
format Online
Article
Text
id pubmed-8785044
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87850442022-02-04 Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics Nij Bijvank, Jenny Uitdehaag, B M J Petzold, Axel J Neurol Neurosurg Psychiatry Multiple Sclerosis BACKGROUND: The visual system could be included in the diagnostic criteria for multiple sclerosis (MS) to demonstrate dissemination in space (DIS) and dissemination in time (DIT). OBJECTIVE: To investigate the diagnostic value of retinal asymmetry in MS. METHODS: A prospective, longitudinal study in individuals with MS (n=151) and healthy controls (n=27). Optical coherence tomography (OCT) was performed at 0, 2 and 4 years. Macular ganglion cell and inner plexiform layer (mGCIPL) thickness was determined as well as measures for retinal asymmetry: the inter-eye percentage difference (IEPD) and inter-eye absolute difference (IEAD). Receiver operator characteristics curves were plotted and the area under the curve (AUC) was calculated for group comparisons of the mGCIPL, IEPD, IEAD and atrophy rates. RESULTS: The diagnostic accuracy of both the IEPD and IEAD for differentiating bilateral and unilateral MS optic neuritis was high and stable over time (AUCs 0.88–0.93). The IEPD slightly outperformed the IEAD. Atrophy rates showed low discriminatory abilities for differentiating MS from controls (AUC 0.49–0.58). CONCLUSION: The inter-eye differences of the mGCIPL have value for demonstration of DIS but in individuals with longstanding MS not for DIT. This may be considered as a test to detect DIS in future diagnostic criteria. Validation in a large prospective study in people presenting with symptoms suggestive of MS is required. BMJ Publishing Group 2022-02 2021-11-11 /pmc/articles/PMC8785044/ /pubmed/34764152 http://dx.doi.org/10.1136/jnnp-2021-327468 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Multiple Sclerosis
Nij Bijvank, Jenny
Uitdehaag, B M J
Petzold, Axel
Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
title Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
title_full Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
title_fullStr Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
title_full_unstemmed Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
title_short Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
title_sort retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
topic Multiple Sclerosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785044/
https://www.ncbi.nlm.nih.gov/pubmed/34764152
http://dx.doi.org/10.1136/jnnp-2021-327468
work_keys_str_mv AT nijbijvankjenny retinalintereyedifferenceandatrophyprogressioninmultiplesclerosisdiagnostics
AT uitdehaagbmj retinalintereyedifferenceandatrophyprogressioninmultiplesclerosisdiagnostics
AT petzoldaxel retinalintereyedifferenceandatrophyprogressioninmultiplesclerosisdiagnostics